Provider [Proveedor]
QP56-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2024
Fecha de entrada en vigencia del programa: 10 de julio de 2024